Eugia Pharma Specialities Limited Tamoxifen Export Data — India (DGFT 2022–2026)

Name: Eugia Pharma Specialities Limited Tamoxifen Export Records India — #1 Exporter, 182 Shipments, $6.7M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Tamoxifen

India Pharmaceutical Trade Intelligence

$14.7M220 Suppliers104 CountriesHS 30049048

ExportsIndia → UNITED STATES42.5%India → GERMANY24.0%

ImportsUNITED STATES → India$2.0M GREECE → India$8.4K

#1 Supplier: EUGIA PHARMA #1 Buyer: AUROBINDO PHARMA

Eugia Pharma Specialities Limited — Tamoxifen Exporter #1 | $6.7M Trade Value | TransData Nexus | TransData Nexus

Eugia Pharma Specialities Limited — Tamoxifen Exporter Profile

Indian Pharmaceutical Exporter · #1 for Tamoxifen · $6.7M export value · DGFT Verified

Eugia Pharma Specialities Limited is the #1 Indian exporter of Tamoxifen with $6.7M in export value and 182 verified shipments. Eugia Pharma Specialities Limited holds a 45.3% market share in Tamoxifen exports across 5 countries. The company exports 49 pharmaceutical products worth $170.1M across 14 therapeutic categories.

Eugia Pharma Specialities Limited — Tamoxifen Export Profile: Buyers & Destinations

Eugia Pharma Specialities Limited Tamoxifen export treemap — buyers and destination countries | TransData Nexus

Where Does Eugia Pharma Specialities Limited Export Tamoxifen?

Country	Value	Shipments	Share
UNITED STATES	$4.6M	155	89.9%
UNITED KINGDOM	$277.0K	10	5.4%
UNITED STATES OF AMERICA	$106.6K	4	2.1%
MALTA	$105.6K	11	2.1%

Who Are the Top Buyers of Tamoxifen from Eugia Pharma Specialities Limited?

Buyer	Country	Value	Orders
AUROBINDO PHARMA USA., INC,	UNITED STATES	$2.1M	85
AUROBINDO PHARMA USA INC	UNITED STATES	$915.1K	25
AUROLOGISTICS LLC, (AUROBINDO PHARM	UNITED STATES	$712.8K	23
AUROBINDO PHARMA USA., INC	UNITED STATES	$301.7K	8
AUROBINDO PHARMA USA.INC.,.	UNITED STATES	$187.7K	4
AUROLOGISTICS LLC AUROBINDO PHARM	UNITED STATES	$184.3K	6
AUROBINDO PHARMA USA. INC	UNITED STATES	$142.5K	4
MILPHARM LIMITED,	UNITED KINGDOM	$101.0K	5
AUROLOGISTICS LLC,	UNITED STATES	$73.5K	2
MILPHARM LIMITED	UNITED KINGDOM	$70.8K	2

Eugia Pharma Specialities Limited supplies Tamoxifen to 22 buyers globally. The largest buyer is AUROBINDO PHARMA USA., INC, (UNITED STATES), followed by AUROBINDO PHARMA USA INC (UNITED STATES) and AUROLOGISTICS LLC, (AUROBINDO PHARM (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Tamoxifen Formulations Does Eugia Pharma Specialities Limited Export?

Product Description / Formulation	Value	Shipments
TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATE	$499.1K	10
TAMOXIFEN TABLET 20MG	$226.6K	6
TAMOXIFEN TABLET 20MG TAMOXIFEN CITRATETABLETS USP 20 MG - US 30 S COUNT QTY: 49581 PACKS	$100.0K	2
TAMOXIFEN TABLETS 20 MG (TAMOXIFEN CITRA	$90.7K	2
TAMOXIFEN TABLET 20MG (Tamoxifen Citrate	$90.2K	2
TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 54666 PACKS)NOS	$76.4K	3
TAMOXIFEN TABLET 20MG (Tamoxifen citratetablets USP 20 mg-US(30's count))	$73.5K	2
TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 26832 PACKS)	$73.5K	2
TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 55402 PACKS)	$71.4K	3
TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATETABLETS USP 20 MG - US (30 S COUNT)) (QTY: 55299 PACKS)	$71.2K	3

Eugia Pharma Specialities Limited exports 115 distinct Tamoxifen formulations including tablets, capsules, syrups, and combination drugs. The top formulation is TAMOXIFEN TABLET 20MG (TAMOXIFEN CITRATE with 10 shipments worth $499.1K.

How Does Eugia Pharma Specialities Limited Compare to Nearest Tamoxifen Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	EUGIA PHARMA SPECIALITIES LIMITED ★	$6.7M	182	5	$36.6K
3	GRANULES INDIA LIMITED	$1.3M	25	2	$50.0K
4	BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED	$830.4K	48	2	$17.3K

Eugia Pharma Specialities Limited ranks #1 among 220 Indian Tamoxifen exporters. Average shipment value of $36.6K compared to the market average of $50.0K. The closest competitors by value are GRANULES INDIA LIMITED and BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED.

Which Indian Ports Ship Tamoxifen Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	776	24.7%
DELHI AIR CARGO ACC (INDEL4)	638	20.3%
SAHAR AIR	541	17.2%
DELHI AIR	301	9.6%
Bombay Air	177	5.6%
Delhi Air	91	2.9%
HYDERABAD AIR	80	2.5%
Bombay Air Cargo	57	1.8%

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Tamoxifen Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Eugia. The Israel-Iran conflict has led to disruptions in Red Sea shipping routes, causing increased freight costs and extended transit times. These logistical hurdles are particularly impactful for time-sensitive pharmaceutical shipments, necessitating strategic adjustments in supply chain management. (pharmaceuticalcommerce.com)

Conversely, U.S.-China trade tensions have opened avenues for Indian exporters. With the U.S. seeking to diversify its supply chains away from China, Indian pharmaceutical companies have the opportunity to capture a larger share of the U.S. market. Eugia's recent FDA approvals and product launches position it well to capitalize on this shift.

However, the imposition of new tariffs by the U.S. administration in August 2025, affecting over 60 countries including India, poses a significant challenge. These tariffs, reaching up to 39%, could impact nearly 55% of India's exports to the U.S., including pharmaceuticals. The increased cost burden may erode profit margins and affect competitiveness in the U.S. market. (apnews.com)

In the European Union, compliance with the Falsified Medicines Directive (FMD) remains a critical requirement. Indian exporters must ensure stringent adherence to serialization and traceability standards to maintain access to the EU market. Eugia's commitment to quality and regulatory compliance will be pivotal in navigating these regulatory landscapes.

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

The global pharmaceutical industry is witnessing heightened regulatory scrutiny, with agencies like the USFDA intensifying inspections and compliance requirements. Eugia's experience with the USFDA's warning letter for its Unit-III facility underscores the importance of robust quality management systems. Addressing these regulatory observations is crucial for maintaining market access and reputation.

Indian pharmaceutical companies, including Eugia, are investing in upgrading manufacturing practices to meet international standards. This proactive approach is essential to mitigate risks associated with non-compliance and to sustain growth in regulated markets.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Tamoxifen shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Eugia Pharma Specialities Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 182 individual customs records matching Eugia Pharma Specialities Limited exporting Tamoxifen, covering 115 formulations to 6 countries via 22 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 104+ countries, 377+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Tamoxifen

Tamoxifen

Eugia Pharma Specialities Limited — Tamoxifen Exporter Profile

Eugia Pharma Specialities Limited — Tamoxifen Export Profile: Buyers & Destinations

Where Does Eugia Pharma Specialities Limited Export Tamoxifen?

Who Are the Top Buyers of Tamoxifen from Eugia Pharma Specialities Limited?

What Is India's Total Tamoxifen Export Value and How Much Does Eugia Pharma Specialities Limited Contribute?

What Is the Average Shipment Value for Eugia Pharma Specialities Limited's Tamoxifen Exports?

How Does Eugia Pharma Specialities Limited Compare to Other Indian Tamoxifen Exporters?

What Tamoxifen Formulations Does Eugia Pharma Specialities Limited Export?

Regulatory Requirements: Exporting Tamoxifen to Key Markets

United States — FDA

United Kingdom — MHRA

How Does Eugia Pharma Specialities Limited Compare to Nearest Tamoxifen Exporters?

Which Indian Ports Ship Tamoxifen Exports?

What Other Advanced Oncology Products Does Eugia Pharma Specialities Limited Export?

Geopolitical & Trade Policy Impact on Eugia Pharma Specialities Limited's Tamoxifen Exports

Eugia Pharma Specialities Limited — Regulatory Compliance & Quality Standards

About Eugia Pharma Specialities Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Tamoxifen Export Data from Eugia Pharma Specialities Limited

Tamoxifen Stats

Company Overview

Top Products by Eugia Pharma Specialities Limited

Related Analysis

Need Detailed Export Data?

Data Source